Patents by Inventor Paul Kellam

Paul Kellam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-malarial antibodies that bind circumsporozoite protein
    Patent number: 11066464
    Abstract: Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: July 20, 2021
    Assignees: KYMAB LIMITED, ATRECA, INC.
    Inventors: Qi Liang, Sean Matthew Carroll, Daniel Eric Emerling, Allan Bradley, Paul Kellam, {hacek over (S)}pela Binter, Simon James Watson
  • KIT FOR AMPLIFYING IMMUNOGLOBULIN SEQUENCES
    Publication number: 20210054434
    Abstract: The invention relates to a kit for amplifying immunoglobulin sequences and methods thereof, and their use and application in methods for the characterisation of a B-cell repertoire.
    Type: Application
    Filed: July 13, 2017
    Publication date: February 25, 2021
    Inventors: Velislava Nikolaeva PETROVA, Rachael BASHFORD-ROGERS, Kenneth SMITH, Paul KELLAM
  • ANTI-MALARIAL ANTIBODIES THAT BIND CIRCUMSPOROZOITE PROTEIN
    Publication number: 20180362628
    Abstract: Antibodies that bind to the circumsporozoite protein (CSP) of Plasmodium falciparum. Use of such antibodies as anti-malarial agents, to confer protection against infection by malarial parasites such as P. falciparum by insect vector transmission. Diagnosis of malaria using anti-CSP antibodies. Methods of determining efficacy of candidate vaccine compositions in development and testing of anti-malarial vaccines.
    Type: Application
    Filed: May 11, 2018
    Publication date: December 20, 2018
    Applicants: KYMAB LIMITED, ATRECA, INC.
    Inventors: Qi Liang, Sean Matthew Carroll, Daniel Eric Emerling, Allan Bradley, Paul Kellam, Spela Binter, Simon James Watson
  • PATHOGEN SCREENING
    Publication number: 20150057160
    Abstract: The present invention relates to methods of isolating pathogenic genomes from a clinical sample.
    Type: Application
    Filed: July 20, 2012
    Publication date: February 26, 2015
    Applicant: UCL BUSINESS PLC
    Inventors: Judith Breuer, Daniel Depledge, Paul Kellam
  • Methods, Compounds and Compositions Relating to Activating a Latent Virus
    Publication number: 20130261137
    Abstract: The present invention relates to, inter alia, an anti-microtubule agent for use in a method of treating a subject having a latent virus, the method comprising: administering the anti-microtubule agent and an anti-viral agent to the subject.
    Type: Application
    Filed: September 9, 2011
    Publication date: October 3, 2013
    Applicant: ULC BUSINESS PLC
    Inventors: Edward Hiu Fung Tsao, Paul Kellam, Richard Gareth Jenner